Skip to main content
Krka
  • About us
  • Products
  • Health matters
  • Investors
  • Media center
  • Employment
EN

Choose a country

Krka around the world

  • Slovenia
  • Global site (English)
  • Austria
  • Belarus
  • Belgium
  • Bulgaria
  • Bosnia and Herzegovina
  • Croatia
  • Czech Republic
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • North Macedonia
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Slovakia
  • Spain
  • Sweden
  • Ukraine
  • United Kingdom

For Healthcare Professionals

Access extended content about our products and healthcare studies.

Login

Do you want to logout?


Logout
  • About us
  • Products
  • Health matters
  • Investors
  • Media center
  • Employment
  • About us
  • Krka at a glance
  • Management
  • International presence
  • Sustainability (ESG)
  • Products
  • Therapeutic areas
  • Clinically proven
  • Science and technology
  • Quality
  • Our products
  • Health matters
  • Articles
  • Investors
  • Financial reports
  • Share trading
  • Financial calendar
  • Shareholder structure
  • Corporate governance
  • Investor information
  • Benefits of owning Krka shares
  • Media center
  • News
  • Multimedia center
  • Employment
  • Join us
  • Why work at Krka?
  • Areas of work
  • Employees share their stories
  • Krka at a glance
  • Our mission, vision and values
  • Development strategy
  • Areas of operation
  • History
  • Identity card
  • Management
  • Management board
  • Supervisory board
  • Sustainability (ESG)
  • Environment
  • Social
  • Governance
  • Therapeutic areas
  • Cardiovascular diseases
  • Gastrointestinal disorders
  • Central nervous system diseases
  • Pain
  • Cough and cold
  • Parasites in dogs and cats
  • Science and technology
  • State-of-the-art technology
  • Achievements
  • Quality
  • Ensuring quality
  • Dedicated to quality
  • Quality management
  • Investor information
  • Corporate releases
  • Investor conferences
  • About Krka shares
  • Dividends
  • Documents
  • Frequently asked questions
  • Areas of work
  • Marketing
  • Sales
  • Corporate performance management
  • Regulatory affairs and pharmacovigilance
  • Production
  • Quality management
  • Engineering and technical services
  • Research and development
  • Supply chain
  • Information technology
  • Environment
  • Strategy and environmental policy
  • Energy and natural resources
  • Environmental impact
  • Social
  • Product quality and patient safety
  • Talent attraction and retention
  • Accessible healthcare
  • Social responsibility
  • Governance
  • Good leadership and governance practices
  • Integrity and transparency
  • State-of-the-art technology
  • Development and production of APIs
  • Development of pharmaceutical products
  • Analytical techniques and research
  • Production of finished products
  • Achievements
  • Bilayer tablets
  • Prolonged-release tablets
  • Osmotic-controlled release innovation
  • Ensuring quality
  • Development and production of APIs
  • Provision of raw materials
  • Development and production of pharmaceutical forms
  • Quality assurance
  • Finished product approval
  • Product distribution
  • Dispensing of medicines and their use
  • About Krka shares
  • Share split
  • Dividends
  • Dividends paid
  • Documents
  • Annual General Meeting
  • Corporate governance documents
  • Disclaimer
  • Information memorandum
  • Social responsibility
  • Partnership
  • Dedicated to sport
  • Dedicated to culture
  • Dedicated to science
  • Supporting healthcare institutions
  • Charity and volunteering
  • Good leadership and governance practices
  • Personal data protection
  • Integrity and transparency
  • Integrity and compliance
  • Krka’s Code of conduct
  • Chief Compliance Officer
  • Transparency and reporting
FONT
SIZE
- 0 +
LOWER/UPPERCASE
Lower UPPER
STYLE
Normal Bold
THEME
  • None
  • Black
    White
  • Show
    images
  • Hide
    Images
Reset Close
HomeKrka websites
Slideshow slide

Krka websites

Corporate websites

  • Slovenia
  • Global page (in English)
  • Austria
  • Belgium
  • Belarus
  • Bolgaria
  • Bosnia and Herzegovina
  • Croatia
  • Czech Republic
  • Estonia
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • North Macedonia
  • Poland
  • Portugal
  • Romunia
  • Russian Federation
  • Slovakia
  • Serbia
  • Spain
  • Sweden
  • TAD Pharma, Germany
  • Ukraine
  • United Kingdom

Health-related webpages

  • General health-related web pages: eZdravje
  • Erectile dysfunction: SI, EN, HR, LT, PL, RU, BG
  • Pets: SI, CZ, LT, PL, RO, RU, HU, UA, HR
  • Products in online pharmacies: SI
  • Great sleep: RU
  • What does your heart beat for: SI

Web applications

  • Krka medicines: SI, HR
  • KrkaVetExpert: SI, EN, RU
  • KrkaStatinCalc: SI, EN, HR
  • KrkaDepLink: EN, AT, RO, HR, PL, LT, RU, SI
  • Breathing exercise: SI
  • Krka4anxiety: CZ, HR, BA
  • KrkaGIriskCalc: EN, RO, LT

Product webpages

  • Septolete: DE, ES, PT
  • Septabene: SI, CZ, LV, FI
  • Septolete extra: SK, HU
  • Septolete duo: HR
  • Septanazal: SI, PL, MK, UA, RU, IE, FI, KZ
  • Septolete Ultra: PL
  • Septolete Total: MK, RU, UA, BY, KZ, AM, UZ, KG, MD
  • Magnezij Krka: SI
  • Panatus: RU
  • Pikovit: BY, UZ, KZ
  • Fitoval: SI, EN, LT, HR
  • Flebaven: SI, RU, SK, PT, UA, HU, MK
  • Nolpaza Control: SI, CZ, PL, SK, UA, UZ, BY, LT
  • Daleron: SI
  • Nalgesin L: HR
  • Nalgesin S: SI, CZ, MK, RU, UA, SK, MD
  • Duovit: RU
  • Fypryst: HU, RO, CZ
  • Bilobil: SI, PL, UA, RU, HU
  • Herbion: SI, MK, RU, UA, UZ, KZ, BY, KG
  • Vizarsin: RU
  • Ulcavis: RU
  • Gingonin: DE
  • B-complex: SI
  • KontrDiar: RU
  • Noctiben Mea: SI
  • Sleepzone: RU
  • Vitamin D3: SI, RO, MK, HR
  • Ecocid S: SI
  • Dasselta: SI
  • Dasmini: CZ
  • Dasseltino: SK

For employees

  • Citrix
  • E-mail
  • eCampus
  • Career webpage

 

Entry points

Healthcare professionals Patients Investors Media Job seekers

Contact us

Contact

Krka, d. d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia

Phone: (+386) 7 331 21 11
Fax: (+386) 7 332 15 37
Email: info@krka.biz

Krka around the world

Follow us

 

Visit our webpages: Terme Krka Krka websites


Legal notice Cookies Personal data protection Entry for partners Map

All rights reserved. Krka, tovarna zdravil, d. d., Novo mesto